Peginterferon

基本解釋

De novo combination therapy with peginterferon and nucleoside analogues should also be studied I think.
對于聚乙二醇干擾素與核苷類似物的聯合初始治療也是需要進一步研究。
The sustained virologic response rate was 79% and 80% in two studies, which was higher than the response rate of 50% with the standard of care with peginterferon plus ribavirin.
在兩項試驗中，持續(xù)的病毒學應答率為79%25和80%25，相比標準治療方案，即長效干擾素聯合利巴韋林的應答率50%25更高。
Peginterferon alfa -2b was prescribed as subcutaneous injection at a dose of 1. 5 mcg/kg/week for patients with body weight less than 65kg or100mcg/week for patients with body weight more than 65kg for 32 weeks.
對于體重小于65 kg患者;按每周每公斤體重1.;5 mcg哌若欣皮下注射; 體重大于65 kg患者;按每周100mcg給藥;均用藥32周。
However, for a straight relapser who was adequately treated with peginterferon and ribavirin the first time around, giving them the same thing again will result in the same outcome.
人們都在關注二甲雙胍和吡格列酮，我認為數據顯示如果你改善他們的胰島素抵抗，那么你可能會改善他們的應答。
peginterferon alfa-2b
聚乙二醇干擾素